HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gang Liu Selected Research

Prolidase Deficiency

9/2009Characterization of prolidase I and II purified from normal human erythrocytes: comparison with prolidase in erythrocytes from a patient with prolidase deficiency.
7/2007Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors.
7/2005Characterization of prolidase activity in erythrocytes from a patient with prolidase deficiency: comparison with prolidase I and II purified from normal human erythrocytes.
12/2004Effects of amino acids and its metabolites on prolidase activity against various iminodipeptides in erythrocytes from normal human and a patient with prolidase deficiency.
1/2004Characteristics of prolinase against various iminodipeptides in erythrocyte lysates from a normal human and a patient with prolidase deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gang Liu Research Topics

Disease

106Neoplasms (Cancer)
12/2015 - 02/2002
25Infection
12/2015 - 11/2003
23Lung Neoplasms (Lung Cancer)
12/2015 - 07/2004
19Fibrosis (Cirrhosis)
12/2015 - 04/2005
19Inflammation
12/2015 - 11/2004
19Neoplasm Metastasis (Metastasis)
04/2015 - 03/2003
15Proteinuria
05/2015 - 07/2003
14Breast Neoplasms (Breast Cancer)
11/2015 - 03/2003
14Alzheimer Disease (Alzheimer's Disease)
01/2015 - 09/2005
13Diabetic Nephropathies (Diabetic Nephropathy)
05/2015 - 11/2005
12Pain (Aches)
09/2015 - 09/2003
12Acute Lung Injury
05/2015 - 11/2004
11Glomerulonephritis
09/2015 - 01/2006
11Lung Diseases (Lung Disease)
05/2015 - 01/2007
11Ischemia
01/2015 - 06/2004
10Membranous Glomerulonephritis (Membranous Nephropathy)
12/2015 - 03/2009
10Heart Failure
09/2015 - 11/2003
9Body Weight (Weight, Body)
08/2015 - 11/2005
9Carcinoma (Carcinomatosis)
10/2014 - 06/2004
9Obesity
01/2010 - 11/2002
7Lung Injury
05/2015 - 07/2008
7Lupus Nephritis
01/2015 - 01/2009
7IGA Glomerulonephritis (IGA Nephropathy)
01/2015 - 01/2004
7Prostatic Neoplasms (Prostate Cancer)
01/2015 - 01/2007
7Chronic Obstructive Pulmonary Disease (COPD)
01/2014 - 05/2003
7Chronic Kidney Failure (Chronic Renal Failure)
01/2014 - 04/2008
6Neurodegenerative Diseases (Neurodegenerative Disease)
04/2015 - 10/2006
6Edema
04/2015 - 11/2007
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2015 - 04/2009
6Anoxia (Hypoxia)
02/2014 - 06/2004
6Sepsis (Septicemia)
01/2014 - 03/2003
6Spinal Cord Injuries (Spinal Cord Injury)
05/2013 - 01/2005
6Cryptorchidism (Undescended Testes)
06/2004 - 11/2002
5Stroke (Strokes)
12/2015 - 05/2010
5Burns
12/2015 - 02/2004
5Asbestosis
05/2015 - 11/2010
5Insulin Resistance
02/2015 - 08/2003
5Tuberculosis (Tuberculoses)
01/2015 - 01/2013
5Pulmonary Fibrosis (Hamman Rich Syndrome)
01/2015 - 11/2010
5Colonic Neoplasms (Colon Cancer)
01/2015 - 04/2007
5Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome)
04/2014 - 01/2006
5Wounds and Injuries (Trauma)
01/2014 - 07/2005
5Disease Progression
10/2011 - 11/2003
5Prolidase Deficiency
09/2009 - 01/2004
4Mesothelioma
05/2015 - 11/2010
4Kashin-Beck Disease
01/2015 - 09/2011

Drug/Important Bio-Agent (IBA)

21MicroRNAs (MicroRNA)IBA
06/2015 - 08/2010
15CreatinineIBA
09/2015 - 11/2005
13Messenger RNA (mRNA)IBA
12/2015 - 07/2005
13Biological Markers (Surrogate Marker)IBA
01/2015 - 04/2010
11IronIBA
12/2015 - 06/2006
11SmokeIBA
12/2015 - 07/2004
11Proteins (Proteins, Gene)IBA
11/2015 - 08/2002
9Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2015 - 04/2009
9Anti-Bacterial Agents (Antibiotics)IBA
10/2014 - 02/2004
9Idiopathic minimal change nephrotic syndromeIBA
07/2014 - 12/2006
9DNA (Deoxyribonucleic Acid)IBA
02/2013 - 03/2003
8Streptozocin (Streptozotocin)FDA Link
05/2015 - 11/2005
8Glucose (Dextrose)FDA LinkGeneric
02/2015 - 04/2009
7AntibodiesIBA
12/2015 - 07/2006
7NF-kappa B (NF-kB)IBA
12/2015 - 09/2005
7ferric oxide (iron oxide)IBA
06/2015 - 04/2011
7Immunoglobulin G (IgG)IBA
01/2014 - 01/2006
7Complementary DNA (cDNA)IBA
02/2007 - 11/2002
6Transcription Factors (Transcription Factor)IBA
12/2015 - 01/2003
6GoldIBA
10/2015 - 04/2011
6Prednisone (Sone)FDA LinkGeneric
09/2015 - 10/2006
6Insulin (Novolin)FDA Link
02/2015 - 11/2002
6Small Interfering RNA (siRNA)IBA
01/2015 - 10/2011
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 11/2003
6Carbon MonoxideIBA
01/2015 - 11/2004
6Interleukin-6 (Interleukin 6)IBA
05/2014 - 09/2008
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014 - 07/2006
6Amino AcidsFDA Link
01/2014 - 01/2003
6Complement System Proteins (Complement)IBA
01/2014 - 07/2003
5EnzymesIBA
12/2015 - 09/2009
5CytokinesIBA
05/2015 - 04/2011
5AsbestosIBA
05/2015 - 11/2010
5Antigen-Antibody Complex (Immune Complex)IBA
01/2015 - 01/2006
5Phosphotransferases (Kinase)IBA
10/2014 - 01/2007
5Amyloid (Amyloid Fibrils)IBA
02/2014 - 10/2006
5Glutamic Acid (Glutamate)FDA Link
01/2014 - 04/2009
5HMGB1 Protein (HMG1)IBA
11/2011 - 09/2008
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2015 - 12/2010
4OxygenIBA
01/2015 - 05/2003
4C-Reactive ProteinIBA
01/2015 - 03/2008
4CollagenIBA
01/2015 - 06/2010
4butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)IBA
01/2015 - 11/2003

Therapy/Procedure

13Heterologous Transplantation (Xenotransplantation)
12/2015 - 04/2011
12Drug Therapy (Chemotherapy)
11/2015 - 11/2004
11Therapeutics
04/2015 - 07/2005
6Radiotherapy
09/2015 - 11/2004
6Lasers (Laser)
04/2015 - 05/2006
5Intraperitoneal Injections
08/2015 - 11/2005
5Photochemotherapy (Photodynamic Therapy)
06/2015 - 08/2013
5Nephrectomy
07/2014 - 11/2005
5Aftercare (After-Treatment)
06/2014 - 07/2010
5Immunotherapy
01/2014 - 07/2008
4Transplants (Transplant)
04/2015 - 05/2006
4Ligation
01/2015 - 07/2007